Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.

Filippatos, Gerasimos; Butler, Javed; Farmakis, Dimitrios; Zannad, Faiez; Ofstad, Anne Pernille; Ferreira, João Pedro; Green, Jennifer B; Rosenstock, Julio; Schnaidt, Sven; Brueckmann, Martina; +4 more... Pocock, Stuart J; Packer, Milton; Anker, Stefan D; EMPEROR-Preserved Trial Committees and Investigators; (2022) Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes. Circulation, 146 (9). pp. 676-686. ISSN 0009-7322 DOI: https://doi.org/10.1161/CIRCULATIONAHA.122.059785

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1161/CIRCULATIONAHA.122.059785

Abstract

Share

Download

Filename: Filippatos_etal_2022_Empagliflozin-for-heart-failure-with.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar